The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

Thanks to a rising prevalence of hearing loss and awareness of rehabilitation options. The cochlear implants market is projected to hit $4.73b by 2030 at a compound annual growth rate of 9.2%, ...

ReadySet Surgical, a health tech company aiming to streamline the surgical supply chain, has its sights set on expansion ...

Envista provided 2025 guidance with core growth expected in the range of 1% to 3%, adjusted EBITDA margin at approximately 14%, and adjusted EPS between $0.95 and $1.05. The company plans to allocate ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

Neuralink's video shows a patient using its brain chip to control a robotic arm, showcasing progress in assistive robotics ...

Analyst Vik Chopra from Wells Fargo maintained a Buy rating on NeuroPace (NPCE – Research Report) and increased the price target to $17.00 from ...